BKYI (BIO-key International) Debt-to-Equity : 0.13 (As of Mar. 2025)

View and export this data going back to 1997. Start your Free Trial

What is BIO-key International Debt-to-Equity?

BIO-key International's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was $0.93 Mil. BIO-key International's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was $0.05 Mil. BIO-key International's Total Stockholders Equity for the quarter that ended in Mar. 2025 was $7.53 Mil. BIO-key International's debt to equity for the quarter that ended in Mar. 2025 was 0.13.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for BIO-key International's Debt-to-Equity or its related term are showing as below:

BKYI' s Debt-to-Equity Range Over the Past 10 Years
Min: -2.15 Med: 0.06 Max: 18.53
Current: 0.13

During the past 13 years, the highest Debt-to-Equity Ratio of BIO-key International was 18.53. The lowest was -2.15. And the median was 0.06.

BKYI's Debt-to-Equity is ranked better than
71.23% of 928 companies
in the Business Services industry
Industry Median: 0.35 vs BKYI: 0.13

BIO-key International Debt-to-Equity Historical Data

The historical data trend for BIO-key International's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BIO-key International Debt-to-Equity Chart

BIO-key International Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Debt-to-Equity

Get a 7-Day Free Trial

0.04

0.02

0.61

0.34

0.47

BIO-key International Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Debt-to-Equity	Get a 7-Day Free Trial															0.58	-2.15	18.53	0.47	0.13

Competitive Comparison of BIO-key International's Debt-to-Equity

For the Security & Protection Services subindustry, BIO-key International's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BIO-key International's Debt-to-Equity Distribution in the Business Services Industry

For the Business Services industry and Industrials sector, BIO-key International's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where BIO-key International's Debt-to-Equity falls into.

Save Embed

;

Save Embed

;

BIO-key International Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

BIO-key International's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.683	+	0.094)	/	3.772
	=	0.47

BIO-key International's Debt to Equity Ratio for the quarter that ended in Mar. 2025 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.926	+	0.054)	/	7.527
	=	0.13

BIO-key International (NAS:BKYI) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

BIO-key International Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of BIO-key International's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

BIO-key International Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » BIO-key International Inc (NAS:BKYI) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

101 Crawfords Corner road, Suite 4116, Holmdel, NJ, USA, 07753

Website

https://www.bio-key.com

BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.

Executives

Michael W Depasquale	director, officer: Co-Chief Executive Officer	1285 CORPORATE CENTER DR, STE 175, EAGAN MN 55121
James David Sullivan	officer: See Remarks	411 WALNUT ST., PMB #15855, GREEN COVE SPRINGS FL 32043
Cameron E. Williams	director	400 N. CASCADES CIRCLE, CANTON GA 30114
Fong Wong Kwok	director	FLAT C, 27/F., BLOCK 5, GRAND PACIFIC VIEWS, SIU LAM K3 00000
Emmanuel Alia	director	15 C SIGNAL HILL ROAD, MADISON CT 06443
Robert J Michel	director	C/O ASTA FUNDING, INC., 210 SYLVAN AVENUE, ENGLEWOOD CLIFFS NJ 07632
Micron Technology Development Ltd	10 percent owner	5/F., SPA CENTRE, 53-55 LOCKHART ROAD, WANCHAI K3 999077
Yick Fabian Shin	director	FLAT B, 23/F, TOWER 2B, 19 TONG YON ST.,, THE WINGS IIIA, TSEUNG KWAN O., NEW TERRITORIES K3 00000
Knook Pieter Cornelis	director	3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719
Jianhui Yao	director	SUITES 2601-2, 26/F TOWER 2, NINA TOWER, 8 YEUNG UK RD, TSUEN WAN K3 TWTL 353
Barbara Rivera	director	C/O BIO-KEY INTERNATIONAL, INC., 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719
Thomas Gilley	director	C/O BIO-KEY INTERNATIONAL, INC., 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719
Iii Thomas Bush,	director	C/O BIO-KEY INTERNATIONAL, INC., 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719
Cecilia C Welch	officer: Chief Financial Officer	PO BOX 588, DUNSTABLE MA 01827
John Schoenherr	director	C/O ORACLE CORPORATION, 10 VAN DE GRAAFF DRIVE, BURLINGTON MA 01803